AltStreet
EDGAR Verified
Primary Source · SEC.gov

TELEMUS LIFE SCIENCE REAL ESTATE FUND, LLC

CIK 0001821602Fund Vehicle2020 vintage506(b)

Raised

$8M

Investors

51

Min Invest

$100,000

AltStreet Analysis

·

Generated from EDGAR primary sources

TELEMUS LIFE SCIENCE REAL ESTATE FUND, LLC is a Delaware-domiciled real estate investment vehicle that filed under Rule 506(b) on September 1, 2020. The fund raised $8.4M from 51 investors with a $100K minimum investment. It is managed by Gary Ran, Matthew Ran, and Eric Oppenheim as executive officers.

This real estate fund employs a 506(b) exemption typical for offerings with pre-existing investor relationships. The $100K minimum investment positions it in the accredited investor retail tier, while the 51-investor count suggests broad distribution relative to the $8.4M raise ($165K average check size).

Data Flags

generalLife science-focused real estate fund is a specialized niche strategy, combining healthcare/biotech property exposure with real estate investment structure
total_investors51 investors for $8.4M raise indicates relatively small average commitment of ~$165K, just above the stated minimum, suggesting retail-focused distribution

EDGAR Filing Data

Form D — Primary Source

View on SEC.gov
CIK Number0001821602
Entity NameTELEMUS LIFE SCIENCE REAL ESTATE FUND, LLC
Exemption506(b)
First Sale Date—
Filing DateSeptember 1, 2020
Accession Number0001821602-20-000001
Total Amount Sold$8M
Total Investors51
Minimum Investment$100,000
Securities TypeEquity
State of IncorporationNot specified
Amendment CountOriginal filing only

Related Persons (Form D)

Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.

Gary Ran

Executive Officer · SOUTHFIELD, MI

Matthew Ran

Executive Officer · SOUTHFIELD, MI

Eric Oppenheim

Executive Officer · SOUTHFIELD, MI

Is this your offering?

Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.

Claim Profile — FreeGet Verified — $2,400/yr

Data Methodology

Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.